Yinghui Chen Selected Research

Kidney Diseases (Kidney Disease)

1/2021

Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yinghui Chen Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 01/2016
11	Neoplasms (Cancer) 11/2022 - 01/2013
6	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 12/2016
6	Epilepsy (Aura) 01/2019 - 01/2017
6	Drug Resistant Epilepsy 01/2018 - 10/2012
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 06/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2011
3	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 06/2013
3	Glioma (Gliomas) 01/2018 - 05/2015
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2012
2	Pathologic Processes 01/2021 - 01/2017
2	Neuroinflammatory Diseases 01/2020 - 01/2018
2	Nervous System Diseases (Neurological Disorders) 01/2018 - 01/2017
2	Leukemia 07/2017 - 10/2012
2	Carcinoma (Carcinomatosis) 06/2013 - 02/2007
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fistula 01/2022
1	Muscle Cramp (Cramp) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Pain (Aches) 01/2022
1	Postoperative Pain 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Rhabdomyolysis 01/2022
1	Muscle Weakness 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Hemangioma (Angioma) 11/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Constipation 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Carcinogenesis 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Lupus Nephritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Wounds and Injuries (Trauma) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017
1	Hypersensitivity (Allergy) 01/2017

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2017
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 10/2012
6	Pharmaceutical PreparationsIBA 01/2018 - 01/2013
5	NAD (NADH)IBA 01/2020 - 06/2013
4	Biological ProductsIBA 11/2021 - 02/2007
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2016
3	astaxanthine (astaxanthin)IBA 01/2020 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 10/2012
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 12/2016
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2013
3	CytokinesIBA 01/2017 - 01/2016
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 01/2016
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	AntigensIBA 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 11/2021 - 01/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2015
2	Circular RNAIBA 01/2021 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2016
2	LithiumIBA 01/2019 - 12/2016
2	Caspase 3 (Caspase-3)IBA 07/2017 - 07/2014
2	thymoquinoneIBA 12/2016 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 06/2013
2	p38 Mitogen-Activated Protein KinasesIBA 07/2015 - 10/2012
2	LipidsIBA 07/2014 - 02/2011
2	SolutionsIBA 06/2013 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 02/2007
1	LeptinIBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	IronIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	OsteopontinIBA 01/2022
1	GlypicansIBA 01/2022
1	Artemether FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Niclosamide FDA Link 01/2020
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	Ethanolamine (Colamine)IBA 01/2020
1	SaltsIBA 01/2020
1	Neuroprotective AgentsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018
1	raf KinasesIBA 07/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	ConvulsantsIBA 12/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2012
2	Microspheres (Microsphere) 06/2013 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2013 - 10/2012
1	Ligation 01/2022
1	Immunotherapy 01/2017